没有 BCMA?没问题:靶向 CD70 的 CAR-NK 细胞在高危骨髓瘤中展现前景 No BCMA? No Problem: A CD70-Targeting CAR-NK Cell Shows Promise in High-risk Myeloma. PubMed 2026/03/04 发表Blood Cancer DiscovQ1 · IF 12.2(JCR 2025) 靶点:CD70靶点:BCMA技术:CAR-NK技术:NK 细胞多发性骨髓瘤地区:美国
靶向 CD70 的 CAR-NK 细胞克服 BCMA 下调并改善高危多发性骨髓瘤模型中的生存 CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models. PubMed 2026/03/04 发表Blood Cancer DiscovQ1 · IF 12.2(JCR 2025) 靶点:CD70靶点:BCMA技术:CAR-NK技术:NK 细胞多发性骨髓瘤地区:美国
多发性骨髓瘤 CAR-NK 细胞治疗的最新进展:细胞来源与靶抗原的综合综述 State of the Art of CAR-NK Cell Therapy in Multiple Myeloma: A Comprehensive Review of Cell Sources and Target Antigens. PubMed 2025/11/20 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:CD38靶点:CD70靶点:BCMA技术:CAR-T技术:CAR-NK技术:NK 细胞
以优化型抗 CD70 CAR-T 细胞靶向高危多发性骨髓瘤基因型 Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells. PubMed 2025/08/14 发表BloodQ1 · IF 23.9(JCR 2025) 靶点:CD70靶点:BCMA技术:CAR-T多发性骨髓瘤地区:美国
多发性骨髓瘤的新型免疫靶点:生物学意义与治疗潜力 Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential. PubMed 2025/07/01 发表Biomark ResQ1 · IF 14.6(JCR 2025) 靶点:CD38靶点:CD70靶点:BCMA技术:双特异性抗体多发性骨髓瘤地区:欧洲
当前抗骨髓瘤 CAR-T 细胞:新型靶点与方法 Current Anti-Myeloma Chimeric Antigen Receptor-T Cells: Novel Targets and Methods. PubMed 2025/07/01 发表Balkan Med JQ1 · IF 4.5(JCR 2025) 靶点:CD19靶点:CD70靶点:BCMA技术:CAR-T技术:NK 细胞技术:基因编辑
多发性骨髓瘤 CAR 治疗的靶点 Targets for CAR Therapy in Multiple Myeloma. PubMed 2025/06/24 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:CD19靶点:CD38靶点:CD70多发性骨髓瘤地区:其他
用优化的抗 CD70 CAR-T 细胞靶向高危多发性骨髓瘤基因型 Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells. PubMed 2024/02/28 发表bioRxiv 靶点:CD70靶点:BCMA技术:CAR-T多发性骨髓瘤地区:美国